115 related articles for article (PubMed ID: 38823729)
1. Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives.
Pang C; Zhao J; Zhang S; Chen J; Zeng X; Li H
Bioorg Med Chem Lett; 2024 May; 109():129824. PubMed ID: 38823729
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.
Wang L; Yao M; Hu Y; Chen C; Jin L; Ma X; Yang H
ACS Med Chem Lett; 2022 May; 13(5):786-791. PubMed ID: 35586422
[TBL] [Abstract][Full Text] [Related]
3. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.
Zhang Y; Feng J; Jia Y; Wang X; Zhang L; Liu C; Fang H; Xu W
J Med Chem; 2011 Apr; 54(8):2823-38. PubMed ID: 21476600
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of tetrahydroisoquinoline stilbene derivatives as potential antitumor candidates.
Li B; Wang J; Yuan M; Miao Y; Zhang H; Zhang J
Chem Biol Drug Des; 2023 Feb; 101(2):364-379. PubMed ID: 36054251
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of diosgenyl quaternary ammonium derivatives and their antitumor activity.
Xia X; Chen Y; Wang L; Yang ZG; Ma XD; Zhao ZG; Yang HJ
Steroids; 2021 Feb; 166():108774. PubMed ID: 33285175
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors.
Wang S; Han S; Cheng W; Miao R; Li S; Tian X; Kan Q
Drug Des Devel Ther; 2022; 16():1083-1097. PubMed ID: 35431540
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
Gangapuram M; Eyunni S; Zhang W; Redda KK
Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs.
Yang Y; Gao Y; Chen S; Guo J; Hu Y
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300453. PubMed ID: 37814371
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives.
Cui H; Zhang R; Xiong X; Cui Z; Min Z; Liu J; Li X; Min Z
Curr Comput Aided Drug Des; 2024 Mar; ():. PubMed ID: 38485684
[TBL] [Abstract][Full Text] [Related]
13. New aryl-/heteroarylpiperazine derivatives of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0
Napiórkowska M; Kurpios-Piec D; Kiernozek-Kalińska E; Leśniak A; Klawikowska M; Bujalska-Zadrożny M
Bioorg Med Chem; 2023 Dec; 96():117518. PubMed ID: 37951135
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives as potential antitumor candidate.
Zhu P; Ye W; Li J; Zhang Y; Huang W; Cheng M; Wang Y; Zhang Y; Liu H; Zuo J
Chem Biol Drug Des; 2017 Mar; 89(3):443-455. PubMed ID: 27717183
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel betulinic acid derivatives.
Yang S; Liang N; Li H; Xue W; Hu D; Jin L; Zhao Q; Yang S
Chem Cent J; 2012 Nov; 6(1):141. PubMed ID: 23174002
[TBL] [Abstract][Full Text] [Related]
17. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Biological Evaluation of Novel Quinoline Derivatives as Potential Anti-Proliferative Agents Against PC-3 and KG-1 Cells.
Li K; Xu Y; Sun J; Zhang W; Ma P
Anticancer Agents Med Chem; 2023; 23(5):599-611. PubMed ID: 35747977
[TBL] [Abstract][Full Text] [Related]
19. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel acenaphthene derivatives as potential antitumor agents.
Xie YM; Deng Y; Dai XY; Liu J; Ouyang L; Wei YQ; Zhao YL
Molecules; 2011 Mar; 16(3):2519-26. PubMed ID: 21415833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
